69605-002 : Beleodaq 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 69605-002 |
Labeler: | Cenexi - Bla |
Product Type: | Human Prescription Drug |
Drug Name: | Beleodaq |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA206256 |
Rev. Date: |
NDC Package Codes:
- 69605-002-01: 1 VIAL IN 1 CARTON (69605‑002‑01) > 10 ML IN 1 VIAL
Active Ingredients:
- Belinostat
Dosage Strength:
- 500 mg/10mL
Pharmaceutical Classes:
- Histone Deacetylase Inhibitor [EPC]
- Histone Deacetylase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 68152-108 Beleodaq 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Spectrum Pharmaceuticals, Inc.
- 72893-002 Beleodaq 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Acrotech Biopharma LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 69605-001Next: 69605-103 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.